NDC codes

FDA NDC Directory
Product NDC (as listed)51655-007Labeler and product segments. Claims need a package NDC.
Product NDC at billing width51655-0007Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
51655-007-275165500072712 TABLET in 1 BOTTLE, PLASTIC (51655-007-27)Marketed from Dec 19, 2022
51655-007-535165500075310 TABLET in 1 BOTTLE, PLASTIC (51655-007-53)Marketed from Nov 22, 2022
51655-007-87516550007876 TABLET in 1 BOTTLE, PLASTIC (51655-007-87)Marketed from Aug 5, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Phenazopyridine Hydrochloride
Generic name (nonproprietary)
phenazopyridine
Active ingredients
Phenazopyridine hydrochloride — 100 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
Unapproved drug (other)
Marketing start
Listing expires
Identifiers
Product ID 51655-007_46dd9f29-5a07-f939-e063-6394a90a6768SPL ID 46dd9f29-5a07-f939-e063-6394a90a6768SPL set ID f29f2ed6-6fd1-fd65-e053-2a95a90aedc4RxCUI 1094107UNII 0EWG668W17

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451655000727 followed by a unit qualifier and the quantity

Package 51655-0007-27. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Phenazopyridine HCl is indicated for the symptomatic relief of pain, burning, urgency, frequency, and other discomforts arising from irritation of the lower urinary tract mucosa caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters. The use of Phenazopyridine HCl for relief of symptoms should not delay definitive diagnosis and treatment of causative conditions. Because it provides only symptomatic relief, prompt appropriate treatment of the cause of pain must be instituted and Phenazopyridine HCl should be discontinued when symptoms are controlled. The analgesic action may reduce or eliminate the need for systemic analgesics …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in